{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:29:21Z","timestamp":1760146161718,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Human mpox (previously known as monkeypox) is a multi-system disease caused by an orthopox DNA virus [...]<\/jats:p>","DOI":"10.3390\/vaccines12101147","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:29:26Z","timestamp":1728361766000},"page":"1147","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccination for Mpox (Monkeypox) Infection in Humans: From Basic Science to Real-World Effectiveness"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-7282","authenticated-orcid":false,"given":"Kay Choong","family":"See","sequence":"first","affiliation":[{"name":"Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore 119074, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cmi.2023.09.004","article-title":"Clinical review of human mpox","volume":"29","author":"Ogoina","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","first-page":"214","article-title":"The need for pre-emptive control strategies for mpox in Asia and Oceania","volume":"9","author":"Gan","year":"2024","journal-title":"Infect. Dis. Model."},{"key":"ref_3","unstructured":"World Health Organization (2024, September 15). WHO Director-General\u2019s Statement at the Press Conference Following IHR Emergency Committee Regarding the Multi-Country Outbreak of Monkeypox\u201423 July 2022, Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022."},{"key":"ref_4","unstructured":"World Health Organization (2024, September 15). WHO Director-General\u2019s Opening Remarks at the Media Briefing\u201411 May 2023, Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing---11-may-2023."},{"key":"ref_5","unstructured":"World Health Organization (2024, September 15). WHO Director-General Declares Mpox Outbreak a Public Health Emergency of International Concern, Available online: https:\/\/www.who.int\/news\/item\/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern."},{"key":"ref_6","unstructured":"World Health Organization (2024, September 15). Mpox, Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mpox."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1016\/S2214-109X(23)00607-1","article-title":"Paediatric, maternal, and congenital mpox: A systematic review and meta-analysis","volume":"12","author":"Coles","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"EVIDoa2300290","DOI":"10.1056\/EVIDoa2300290","article-title":"Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults","volume":"3","author":"Morino","year":"2024","journal-title":"NEJM Evid."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Noyce, R.S., Westfall, L.W., Fogarty, S., Gilbert, K., Mpanju, O., Stillwell, H., Esparza, J., Daugherty, B., Koide, F., and Evans, D.H. (2023). Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge. Viruses, 15.","DOI":"10.3390\/v15020356"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"eadl4317","DOI":"10.1126\/scitranslmed.adl4317","article-title":"Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques","volume":"16","author":"Ty","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2278900","DOI":"10.1080\/22221751.2023.2278900","article-title":"Non-replicating vaccinia virus NTV as an effective next-generation smallpox and monkeypox vaccine: Evidence from mouse and rhesus monkey models","volume":"12","author":"Chu","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114269","DOI":"10.1016\/j.celrep.2024.114269","article-title":"Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2400139","DOI":"10.2807\/1560-7917.ES.2024.29.34.2400139","article-title":"Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022","volume":"29","author":"Colombe","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMc2300805","article-title":"Effectiveness of Smallpox Vaccination to Prevent Mpox in Military Personnel","volume":"389","author":"Titanji","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e078243","DOI":"10.1136\/bmj-2023-078243","article-title":"Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: Emulation of a target trial","volume":"386","author":"Navarro","year":"2024","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(23)00057-9","article-title":"Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: An observational study","volume":"23","author":"Bertran","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study\u2014United States, August 19, 2022-March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection\u2014New York, 2022","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/cid\/ciad645","article-title":"Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study","volume":"78","author":"Hernando","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"125987","DOI":"10.1016\/j.vaccine.2024.05.035","article-title":"Effectiveness of JYNNEOS vaccine against symptomatic mpox disease in adult men in Los Angeles County, August 29, 2022 to January 1, 2023","volume":"42","author":"Yeganeh","year":"2024","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Back, S., Knox, B., Coakley, C., Deltour, N., Jacquot, E., Raad, H., and Garry, E.M. (2024). Effectiveness and Safety of the MVA-BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc). Vaccines, 12.","DOI":"10.3390\/vaccines12060651"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cid\/ciad584","article-title":"Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk","volume":"78","author":"Brousseau","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jiph.2024.02.015","article-title":"Breakthrough cases of mpox: One-dose vaccination is associated with milder clinical manifestations","volume":"17","author":"Allard","year":"2024","journal-title":"J. Infect. Public Health"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.jvacx.2024.100527","article-title":"Assessment of the knowledge, attitude, and perception of the world\u2019s population towards monkeypox and its vaccines: A systematic review and descriptive analysis of cross-sectional studies","volume":"20","author":"Tanashat","year":"2024","journal-title":"Vaccine X"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s43856-024-00564-1","article-title":"Global prevalence and correlates of mpox vaccine acceptance and uptake: A systematic review and meta-analysis","volume":"4","author":"Sulaiman","year":"2024","journal-title":"Commun. Med."},{"key":"ref_29","first-page":"2400575","article-title":"Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023","volume":"29","author":"Shamier","year":"2024","journal-title":"Eurosurveillance"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/10\/1147\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:08:58Z","timestamp":1760112538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/10\/1147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["vaccines12101147"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12101147","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}